ENERGY METABOLISM STATUS IN ACUTE PERIOD OF ISCHEMIC STROKE

Abstract


Aim. To study the peculiarities of carbohydrate metabolism in the acute period of ischemic stroke. Materials and methods. Sixty two patients with primary ischemic stroke associated with arterial hypertension and free of diabetes mellitus in anamnesis were examined. Fasting blood glucose, immunoreactive insulin and C-peptide levels were determined. Insulin resistance was assessed using calculation index HOMA and coefficient Caro. Results. Increase in glycemia levels to 5,31 ± 0,68 mmol/l, C-peptide to 0,90 ± 0,31 nmol/l and decline in insulin level to 9,38 ± 4,34 mcME/ml was demonstrated. C-peptide to insulin ratio values were reliably higher in patients with severe course of stroke (by 35,6 %, p < 0,05) and unfavorable outcome of disease (by 39,6 %, p < 0,05). Conclusions. Development of ischemic stroke is accompanied by high blood C-peptide levels against the background of hypoinsulinemia and minor hyperglycemia. Manifestation of disorders correlates with severity and clinical outcome of disease.

About the authors

G I Izhbuldina

Email: gulnara-ufa@list.ru

References

  1. Виленский Б. С. Инсульт - современное состояние проблемы. Неврологический журнал 2008; 2: 4-10.
  2. Гусев Е. И., Скворцова В. И., Стаховская Л. В. Проблема инсульта в Российской Федерации: время активных совместных действий. Журнал неврологии и психиатрии им. Корсакова 2007; 8: 4-8.
  3. Дедов И. И., Шестакова М. В. Сахарный диабет и артериальная гипертензия. М: МИА 2006; 344.
  4. Li Y., Meng L., Li Y., Sato Y. Associations of serum C-peptide level with body fat distribution and ever stroke in nondiabetic subjects. J. Stroke Cerebrovasc. Dis. 2014; 23: 163-169.
  5. Badiger Sh., Akkasaligar P.T., Narone U. Hyperglycemia and stroke. Int. J. Stroke Res. 2013; 1: 1-6.
  6. Clark M. E., Payton J. E., Pittiglio L. I. Acute ischemic stroke and hyperglycemia. Critical Care Nursing Quarterly 2014; 37: 182-187.
  7. Mavrakanas T., Frachebois C., Soualah A., Aloui F., Julier I., Bastide D. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome. Presse Medicale 2009; 38: 1399-1403.
  8. Rundek T., Gardener H., Xu Q., Goldberg R. B., Wright C. B., Boden-Albala B., Disla N., Paik M. C., Elkind M. S., Sacco R. L. Insulin resistance and risk of ischemic stroke among non-diabetic individuals from the northern Manhattan study. Arch. Neurol. 2010; 67: 1195-1200.
  9. Urabe T., Watada H., Okuma Y., Tanaka R., Ueno Y., Miyamoto N., Tanaka Y., Hattori N., Kawamori R. Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in Japanese patients. Stroke 2009; 40: 1289-1295.
  10. Vasic D., Marx N., Sukhova G., Bach H., Durst R., Grüb M., Hausauer A., Hombach V., Rottbauer W., Walcher D. C-peptide promotes lesion development in a mouse model of arteriosclerosis. J. Cell. Mol. Med. 2012; 16: 927-935.

Statistics

Views

Abstract - 3178

PDF (Russian) - 195

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Comments on this article

Comments on this article

View all comments

Copyright (c) 2015 Izhbuldina G.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies